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Abstract 
 
Study design: Prospective multi-center cohort study. 
Objectives:This study evaluates the risk for surgical site infections (SSI) or wound healing 
problems (WHP) in patients who underwent corticosteroid injection prior to lumbar 
decompression surgery.  
Summary of Background Data:Corticosteroid injections are often used for the treatment of the 
degenerated spine. However, their well-known immunosuppressive effects could increase the 
risk for local infections, particularly if a surgical intervention follows the injection rapidly.  
Methods:The Swiss Lumbar Stenosis Outcome Study (LSOS), which is a prospective 
multicenter cohort study of patients with symptomatic lumbar spinal stenosis, was used as 
database. Of 743 patients, 422 patients underwent surgery and were eligible for the study. 
Tenpatients (2.4%) were revised for either surgical site infections (n=6) or wound healing 
problems (n=4). A control group (n=19) was constructed matched according to age, sex, diabetes 
and BMI. Odds ratios were calculated by using a conditional logistic regression model to 
quantify the risk of SSI or WHP after pre-operative corticosteroid injection. Subgroup analysis 
was performed for patients with injection within 0-3 months before surgery, 0-6 months before 
surgery or any injection at all before surgery. 
Results:Within this cohort, no significant association could be found between preoperative 
corticosteroid injection and postoperative SSI or WHP in patients with corticosteroid injections 
within 0-3 months before surgery (OR = 0.36, 95% CI 0.04-3.22), 0-6 months before surgery 
(OR = 0.69 95% CI 0.14-3.49) or any time before surgery (OR = 0.43, 95% CI 0.04-3.22).  
Conclusions:Within the here investigated cohort, the risk of surgical site infections or wound 
healing problems following lumbar spinal decompression surgery seems not highly associated 
with preoperative corticosteroid injections. However, the safe time interval between 
corticosteroid infiltrations and surgery remains unknown,should not be decreased incautiously 
and is subject of further research.  
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Introduction 
 
The most common reason for spinal surgery in elderly people is lumbar spinal stenosis 
(LSS)with increasing rates by aging of the population.1,2 The natural history of mild and 
moderate LSS is favorable in one-third to half of the patients.3 First-line treatment options of 
LSS are usually non-surgical. A potential effect of physical therapy, orthotics, rehabilitation, 
exercise, pain killers/ NSAIDs, education, heat and cold applications and electrical nerve 
stimulation or alike find low evidence.4 Epidural injections of a corticosteroid (ESI) seem 
however to provide short-term (two weeks to six months) symptom relief in patients with 
neurogenic claudication or radiculopathy but with conflicting evidence regarding the long-term 
efficacy.3 The number of epidural injections being performed is increasing although the potential 
of severe adverse effects is not to be neglected.5–7 According to the US Food and Drug 
Administration (FDA), the administration of corticosteroids in the epidural space is considered 
off-label use and its use should carefully follow guidelines.3,8–10Surgical decompression usually 
follows failed conservative treatment and provides a long-term pain relief in a large percentage 
of patients. 3,11The perioperative morbidity, despite the advanced age of the average patient, 
seems relatively low.12,13One of the potentially serious complications of spinal surgery is 
infection with an incidence of 0.7- 12%.14,15Compared to that, the infection rate after spinal 
injections is reported to be 1-2% but still with possible devastating consequences for the 
patient.7,16 The immunosuppressive effect of corticosteroids is well known.17–20 Although 
frequently used in the treatment of LSS, ESI prior or even during surgery has not been 
sufficiently acknowledged or investigated as a potential risk factor for a postoperative 
SSI.21,22Yang et al. published very recently a retrospective analysis of a database with 18’931 
patients; the patients were assigned to one of the following groups: Lumbar epidural steroid 
injections within 0-1 month, 1-3 months, 3-6 months or 6-12 months between injection and 
surgery.21 They identified patients with injection 0-1 and 1-3 months before surgery at higher 
risk for postoperative infections. However, as the retrospective analyses originate form data of a 
large heterogeneous database, the potential of indication and selection bias is considered high 
and more clinically granular research was suggested by the editors.  
The aim of this study was to evaluate the risk for surgical site infections (SSI) or wound healing 
problems (WHP) in patients who received a local corticosteroid injection prior to lumbar 
decompression surgery with or without fusion using a very detailed prospectively established 
national multicenter database. If so, the minimal time interval between injection and surgical 
intervention could be defined to minimalize the risk of surgical site infections or wound healing 
problems.  
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Methods  
 
The Lumbar Stenosis Outcome Study (LSOS), an ongoing, prospective, multicenter cohort with 
patients recruited from several hospitals in Switzerland, was used.23 This multi-center cohort 
study was conducted in compliance with all international laws and regulations as well as any 
applicable guidelines. Written informed consent to participate in the study has been obtained 
from participants. The study was approved by the independent Ethics Committee of the Canton 
Zurich (KEK-ZH-NR: 2010-0395/0). Inclusion criteria for the cohort were symptomatic LSS 
with unilateral or bilateral neurogenic claudication, age of 50 years or older and radiographically 
verified spinal stenosis (CT or Magnetic Resonance Imaging). Further, the life expectancy had to 
be more than one year and the patients had to be available for follow-up during at least one year. 
Exclusion criteria for the cohort were a caudaequina syndrome requiring urgent surgery, acute 
fracture, infection or significant deformity (>15° lumbar scoliosis) and a clinically relevant 
peripheral arterial disease.A database query was performed on 743 patients to identify the case 
group with patients with a surgical site infection (SSI) or a wound healing problem (WHP) after 
primary decompression and/or fusion for LSS who underwent revision surgery for that reason. 
These patients of the case group were matched to a control group according to age and sex, and 
thepresence of risk factors for postoperative infections in spine surgery likediabetes and BMI. 
According to a recent meta-analysis, a match for smoking status was abandoned as it was not 
shown as an independent risk factor for SSI in spinal surgery.24 
The number of corticosteroid injections and time interval to surgery was determined. Injections 
to different regions or different levels on the same date (e.g. to the facet joints and epidural) were 
not discriminated.Intraoperative application of corticosteroid in surgical treatment of LSS is 
considered obsolete in Switzerland and therefore this potential bias was not monitored. 
In addition, established clinical outcome score such as Symptom Severity Scale (SSM), Roland 
Morris Disability Scale (RMDQ), Pain numeric rating scale (NRS) and EuroQol-5D (EQ-5D) 
were determined for each of the subgroups at baseline and the last visit after 24 months.  
The SSM, an instrument specifically developed and validated for spinal stenosis patients by 
Stucki et al., targets to measure severity of symptoms and quantifies disability of the lumbar 
spinal stenosis population.25–28It consists of three different subscales; the symptom severity 
subscale, the physical function subscale and the satisfaction with treatment results subscale with 
score ranges from 1-5 and 1-4 (best-worst). The Roland and Morris Disability Questionnaire is a 
back pain specific, self-rated physical disability questionnaire developed by Roland and Morris 
in 1983.29 The maximum number of points is 24 and indicates severe disability.30 The EQ-5D-3L 
is an assessment tool to measure health-related quality of lifewith five dimensions of health 
(mobility, self-care, usual activities, pain/discomfort and anxiety/depression) which can be 
calculated as a sum score (score range 0-100, worst-best).31,32 
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Statistical analyses 
The software “R” was used for the statistical analysis.33 Descriptive statistics are reported as 
mean and standard deviations (SD) for continuous variables and numbers and percentages of 
total for the categorical variables. A matched case-control study design was employed to address 
the influence of pre-operative epidural injections on the rare event of SSI or WHP. Patients with 
infections or wound healing problems were defined as “cases”. Control patients were matched to 
the cases, if the variables age (±2 years), gender, BMI (≥ 30 kg/m2), and diabetes were identical. 
A conditional logistic regression approach was used with the advantage that all available control 
patients could be included, i.e. resulting in either one or more control patients for each case. 
Odds ratios were calculated to quantify the effect of pre-operative epidural infections on SSI or 
WHP; either overall, or within specified time periods up to three or six months before surgery. A 
p-value of <0.05 was defined as statistically significant.  
 
Results 
Of 743 patients included in the Lumbar Stenosis Outcome Study (LSOS) cohort, 422 patients 
(57%) were treated with spinal surgery (Figure 1). Of those, a total of ten patients (2.4%) 
underwent revision surgery either for SSI (n=6) or WHP (n=4) (Table 1). 
Patients who were revised for a SSI had a mean age of 70.7 (standard deviation (SD) 10.5) years, 
a mean BMI of 29.5 (SD 4.3) kg/m2 and one-third were females. Only one of the patients 
(16.7%) had a reported diabetes mellitus. Four of the six patient (66%) with SSI had injections 
prior to surgery (a total of 15 injections).  
Patients who were revised for a WHP had a mean age of 65 (SD 4.2) years, mean of BMI 33.8 
(SD 1.9) kg/m2 and three (75%) of the patients were female. Two (50%) of the patients had a 
reported diabetes mellitus. Only one patient (25%) had corticosteroid injections before surgery (a 
total of two injections) (Table 1).  
The control group was constructed with all 19 patients out of the 412 remaining surgical patients 
who were matched (mean age of 71 (SD 8.54) years, four (21%) females, mean BMI 29.7 (SD 
5.3) kg/m2, one (5.3%) patient with diabetes) according to the above-mentioned criteria. 
Fourteen of these 19 patients (73.7%) had an injection before surgery (Table 1). 
Combining the SSI and WHP subgroup, the total amount of injections in the combined case 
group was 5 of 10 patients (50%) compared to 14 injections in 19 control patients (74%) 
(p=0.73). No significant association could be found between preoperative corticosteroid injection 
and postoperative surgical site infections or wound healing problems in patients with 
corticosteroid injections within 0-3 months before surgery (odds ratio (OR) = 0.36, 95% 
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confidence interval (CI) 0.04-3.22), 0-6 months before surgery (OR = 0.69, 95% CI 0.14-3.49) or 
any injection at all before surgery (OR = 0.43, 95% CI 0.04-3.22) (Table 2). 
Neither the values of the symptom severity scale (SSM), nor those of the Roland and Morris 
Disability Questionnaire, the pain intensity scale (numeric rating scale NRS) or the EuroQol-5D 
(EQ-5D-3L) scores were significantly different between the combined case group (SSI und 
WHP) compared to the matched control group (Table 3).  
 
Discussion 
We aimed to illuminate whether local corticosteroid injection prior to lumbar decompression 
surgery is potentially a clinically relevant independent risk factor for postoperative surgical site 
infection (SSI) or wound healing problems (WHP) and to determine the minimal safe time 
interval between injection and surgery. Potential confounding factors were limited to a minimum 
through use of a large prospective multicenter national cohort and a matched case-control study 
design. 
We found no statistical difference in the calculated odds ratios between the group of 
patients who developed a SSI or WHP compared to the matched control group, no matter 
if the injections were made within 3 months, 6 months or at any time point before surgery.  
It is known that aseptic surgical techniques and prophylactic preoperative antibiotics are the most 
important measures to prevent surgical site infections.34,35 Further, several patient associated risk 
factors have been identified for SSI including diabetes and obesity. Other risk factors such as 
smoking are debatable.24 It is questionable how strong local steroids would be a relevant risk 
factor for SSI or WHP, although the anti-inflammatory as well as the immunosuppressive effects 
of cortisone are well known.17–20 This lack of information is even more surprising knowing that 
the systemic use of corticosteroids increases the rate of wound healing problems.36 
Intraoperative administration of epidural cortisone has been suggested to improve 
postoperative pain and to decrease the average length of hospital stay, however, an increase 
of postoperative epidural abscess formation after intraoperative epidural cortisone 
administration has been reported and therefore limits the advantages of the procedure.37–40 
Our results concerning injections within 3 months before surgery are in concordance with 
the recent report by Seavey et al of a large sample size41, but indiscordance of those 
reported by Yang et al. who clearly have found associations between time-interval of 
corticosteroid injections and the increase of surgical site infections.21 This might be because 
of several differences in the study designs and populations, such as a much smaller sample 
size in our cohort or inclusion of patients over 50 vs. 65 years. However, the here presented 
results are based on a database with meticulous prospective data gathering methodology 
focusing on patients with a lumbar spinal stenosis on a multi-institutional level compared 
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to the large but less detailed database in the study of Yang et al. A major limitation of both 
studies is the definition of SSI. It is known that such can affect the reported rate of surgical 
site infections substantially.42–48 In our study, we clearly focused on SSI or WHP severe 
enough to undergo surgery. But again, the indication for such a revision surgery was not 
standardized in the here used multi-center cohort. The here presented results have 
therefore to be interpreted in respect to this prominent limitation and also other kind of 
limitations. First, the relatively small number of patients who actually developed SSI or 
WHP might limit the statistical power, but since a rare event is being investigated, this 
limitation cannot be easily eliminated. We tried to account for this limitation by reduction 
of the potential confounding factors with the matched case-control design and by using the 
largest possible national cohort in our country with maximal accuracy of the available 
dataand a reasonable follow up time of 24 to 36 months. It is certainly not excluded, rather 
plausible, that a statistical difference could be found with larger numbers. However, such a 
potential difference would probably not be clinically relevant enough, considering that 
corticosteroid infiltrations areestablished as a cornerstone of conservative treatment of LSS 
to be performed before indicating a surgical procedure. However, further research could 
focus on potential associations and the safest time interval between corticosteroid injections and 
surgery. Second, the injection technique per se could carry different risks of injections 
theoretically, although rates of infections after corticosteroid injections of the spine are very low 
(level of case reports). Further, with the same type of corticosteroids in all centers and the 
matched case control design of this multicentered national study, this potential bias can be 
considered to be diluted, if at all present. Third, other potential confounding factors such 
as intake of other immunosuppressive medication or surgical aspects such as time of 
surgery and amount of blood loss are not considered here since the sample size of the rare 
event of infections is too small for stratification. 
With respect to the mentioned limitations, we conclude that the risk of surgical side 
infections or wound healing after lumbar spinal decompression surgery seems not significantly 
correlated to preoperative corticosteroid infiltrations. 
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Table 1: Baseline Demographics of the study groups. BMI: Body Mass Index, SD: 
Standard Deviation 
Demographics Surgical site 
infection (SSI) 
Wound healing 
problem (WHP) 
Controls 
n 6 4 19 
Age, mean (SD), years 70.7 (10.5) 65.00 (4.2) 71 (8.5) 
Female, n (%) 2 (33) 3 (75) 4 (21) 
BMI, mean (SD), kg/m2 29.5 (4.3) 33.8 (1.9) 29.7 (5.3) 
Diabetes, n (%) 1 (16.7) 2 (50) 1 (5.3) 
Number of patients with a 
preoperative corticosteroid 
injection, n (%) 
 
4 (66) 1(25) 14 (73.7) 
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Table 2: Odds-ratios andconfidence Intervals reflecting the ratio of odds for SSI or WHP 
in patients with corticosteroid infiltrations as compared to patients without. 
 
  
Exposition Odds-ratio 95%- Confidence-Interval (CI) 
Injection  
at any time point  
before surgery 
0.43 0.40 – 3.22 
Injection  
within 6 month  
before surgery 
0.69 0.14 -3.49 
Injection  
within 3 month  
before surgery 
0.36 0.04-3.22 
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Table 3: Clinical outcome scores of patient with a SSP or WHP compared to the matched 
control group. SSI: Surgical Site Infection, WHP: Wound Healing Problem SSM: 
Symptom Severity Scale 
Outcome Baseline 24 month p-value* 
SSM (SSM symptom severity scale): Symptoms    
SSI + WHP 3.4 2.3 0.84 Controls 3.3 2.1 
SSM (SSM physical function subscale): Function    
SSI + WHP 2.6 1.4 0.23 Controls 2.4 1.6 
SSM (SSM symptom severity scale): pain domain    
SSI + WHP 3.9 2.4 0.74 Controls 3.8 2.4 
SSM (SSM symptom severity scale): 
neuroischemic    
SSI + WHP 3 2.2 0.92 Controls 2.7 1.9 
Roland and Morris Disability Questionnaire    
SSI + WHP 13.3 9 0.33 Controls 12.6 6.5 
Pain Intensity Scale (numeric rating scale NRS)    
SSI + WHP 7.1 3.2 0.86 Controls 6.9 3.5 
EuroQol-5D (EQ-5D-3L)    
SSI + WHP 67 86.7 0.73 Controls 65.8 82.3 
* p-value from independent samples Wilcoxon test of the changes from baseline to 24 months 
between SSI+WHP and controls. 
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